{"title":"治疗慢性髓性白血病,有哪些药物?多久?多少钱?","authors":"M. Baccarani","doi":"10.2217/IJH.15.14","DOIUrl":null,"url":null,"abstract":"“...the already excellent results of treatment can be optimized, but optimization aiming at a sustainable extension of the treatment worldwide, at a more cost-effective use of the available drugs and at more attention to the quality of life, requires a long and a demanding learning curve.”","PeriodicalId":14166,"journal":{"name":"International Journal of Hematologic Oncology","volume":"4 1","pages":"93-97"},"PeriodicalIF":0.0000,"publicationDate":"2015-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/IJH.15.14","citationCount":"0","resultStr":"{\"title\":\"Treatment of chronic myeloid leukemia, which drugs? How long? How much?\",\"authors\":\"M. Baccarani\",\"doi\":\"10.2217/IJH.15.14\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"“...the already excellent results of treatment can be optimized, but optimization aiming at a sustainable extension of the treatment worldwide, at a more cost-effective use of the available drugs and at more attention to the quality of life, requires a long and a demanding learning curve.”\",\"PeriodicalId\":14166,\"journal\":{\"name\":\"International Journal of Hematologic Oncology\",\"volume\":\"4 1\",\"pages\":\"93-97\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-10-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2217/IJH.15.14\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Hematologic Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2217/IJH.15.14\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Hematologic Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/IJH.15.14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Treatment of chronic myeloid leukemia, which drugs? How long? How much?
“...the already excellent results of treatment can be optimized, but optimization aiming at a sustainable extension of the treatment worldwide, at a more cost-effective use of the available drugs and at more attention to the quality of life, requires a long and a demanding learning curve.”
期刊介绍:
International Journal of Hematologic Oncology welcomes unsolicited article proposals. Email us today to discuss the suitability of your research and our options for authors, including Accelerated Publication. Find out more about publishing open access with us here.